Acthera Therapeutics: Funding, Investors & Team (Sep 2026)
Acthera Therapeutics is a biotech startup developing an innovative targeted drug release technology platform.
Acthera Therapeutics has raised $5.9M across 3 funding rounds on record, the most recent an undisclosed round announced in Dec 2022.
Acthera Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2022.
Acthera Therapeutics Funding Rounds
2 of 3 rounds were announced without a disclosed amount and are excluded from the total.
Acthera Therapeutics raised $5.9M in a Seed announced in Jul 2021.
10 months later, a Seed was announced in May 2022 with no disclosed amount.
7 months later, an undisclosed round was announced in Dec 2022 with no disclosed amount.
Acthera Therapeutics Founders and Leadership Team
Contact details for the Acthera Therapeutics team: 1 of 3 have an email address on file.
Start 14-day free trial →Acthera Therapeutics Funding Compared to Other Biotechnology Startups
Funded Startups Like Acthera Therapeutics in Biotechnology and Basel
Companies Similar to Acthera Therapeutics
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
Acthera Therapeutics Funding FAQs
What does Acthera Therapeutics do?
Acthera Therapeutics is a biotech startup developing an innovative targeted drug release technology platform.
How much funding has Acthera Therapeutics raised?
Acthera Therapeutics has raised $5.9M across 3 rounds on record.
When did Acthera Therapeutics last raise funding?
Acthera Therapeutics' most recent funding round on record was announced in Dec 2022. The amount was not disclosed.
Who founded Acthera Therapeutics?
FundedIQ lists Andreas Zumbuehl (Founder) at Acthera Therapeutics.
Who is the CEO of Acthera Therapeutics?
Pierre-Alain Monnard is listed as CEO at Acthera Therapeutics.
Where is Acthera Therapeutics headquartered?
Acthera Therapeutics is based in Basel, Basel-Stadt, Switzerland.
How many employees does Acthera Therapeutics have?
Acthera Therapeutics is in the 1-10 employee band.
About FundedIQ's Acthera Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Acthera Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.